Functional Oligonucleotides
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT06258330
Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 22, 2022
Completion: Oct 1, 2024
Loading map...